Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1

Kathrin Burgmaier1, Leonie Brinker2, Florian Erger3

  • 1Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany; Center for Rare Diseases, University Hospital Cologne and Medical Faculty, University of Cologne, Cologne, Germany.

Insights

New findings reveal specific PKHD1 gene regions linked to Autosomal recessive polycystic kidney disease (ARPKD) severity. Understanding these genotype-phenotype correlations aids personalized ARPKD patient care.

Area of Science:

  • Genetics
  • Pediatric Nephrology
  • Molecular Medicine

Background:

  • Autosomal recessive polycystic kidney disease (ARPKD) is a severe early childhood condition.
  • Fibrocystic kidney and liver changes characterize ARPKD, primarily caused by PKHD1 gene variants.
  • Clinical heterogeneity in ARPKD is not fully understood, with limited genotype-phenotype data.

Purpose of the Study:

  • To identify novel genotype-phenotype correlations in ARPKD patients.
  • To analyze deep clinical data from a large ARPKD cohort.
  • To improve understanding of ARPKD heterogeneity in children and adolescents.

Main Methods:

  • Observational study of 304 ARPKD patients from two independent cohorts.
  • Analysis of deep clinical datasets.
  • Correlation of PKHD1 gene variant locations with clinical outcomes.

Main Results:

  • Biallelic null variants in PKHD1 are frequently associated with severe ARPKD.
  • Specific missense variant regions in fibrocystin correlate with kidney and liver outcomes.
  • Variants in PKHD1 amino acids 709-1837 linked to reduced chronic kidney failure risk.
  • Variants in amino acids 1838-2624 associated with better liver outcomes, while 2625-4074 linked to poorer outcomes.

Conclusions:

  • Novel genotype-phenotype correlations in pediatric ARPKD are identified.
  • The affected region within the PKHD1 gene influences ARPKD phenotype.
  • Findings support more precise genetic counseling and personalized treatment strategies for ARPKD.